News & Events

HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements

TUCSON, Ariz., Sept. 18, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that is has successfully completed an audit of its Quality Management System for continued certification to ISO 13485. This certification was issued by a registrar accredited under the Canadian Medical Device Conformity Assessment System (CMDCAS), which is required by Health Canada for the company to market in vitrodiagnostic (IVD) products in Canada.

full press release

Posted on:

Return To List

Page last updated December 20, 2017